00173-0913 Blenrep - CanMED: NDC

Product NDC:

00173-0913

Brand Name:

Blenrep

Generic Name:

Belantamab mafodotin

Dosage Form Name:

INJECTION, POWDER, FOR SOLUTION

Administration Route:

Intravenous

Substances:

Name: BELANTAMAB MAFODOTIN

Strength: 50.0

Unit: mg/mL

Packages:

Code: 00173-0913-01

Description: 1 VIAL in 1 CARTON (0173-0913-01) / 1.4 mL in 1 VIAL

Effective Date: Oct. 23, 2025

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Drug Antibody Conjugate

Minor Class:

BCMA

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox